SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000769993-22-000244
Filing Date
2022-03-10
Accepted
2022-03-10 15:26:43
Documents
1
Group Members
GOLDMAN SACHS & CO. LLC

Document Format Files

Seq Description Document Type Size
1 QUOIN PHARMACEUTICALS, LTD. QUOIN_Final.txt SC 13G/A 21823
  Complete submission text file 0000769993-22-000244.txt   23664
Mailing Address 200 WEST STREET NEW YORK NY 10282
Business Address 200 WEST STREET NEW YORK NY 10282 212-902-1000
GOLDMAN SACHS GROUP INC (Filed by) CIK: 0000886982 (see all company filings)

IRS No.: 134019460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6211 Security Brokers, Dealers & Flotation Companies

Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Subject) CIK: 0001671502 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: SC 13G/A | Act: 34 | File No.: 005-89873 | Film No.: 22728876
SIC: 3841 Surgical & Medical Instruments & Apparatus